London, 19/12/2019 – Halma today announces that it has agreed a strategic partnership with Owlytics Healthcare an Israeli company specialising in wearable-based analytics technology for the medical sector.
Owlytics provides remote patient-monitoring solutions for independent and assisted living facilities, home care agencies and other services that provide a high level of personal care and safety. The company develops wristband-based signal analytics that collect personal health data so that machine-learning algorithms can assess personal fall risk and auto-detect fall events and abnormal physiological patterns, thereby enabling preventative care.
Halma has taken a minority equity stake, which will enable Owlytics to accelerate its marketing and sales efforts with US senior living and collaborative care health insurance providers. The partnership will also bring new technologies and capabilities to companies within Halma’s Medical sector already operating in this market niche.
A-round investors also include investment from Consensus Business Group, chaired by Mr Vincent Tchenguiz, which has a specialist focus on innovative, high growth ventures in the healthcare and medtech sectors, and returning private investors Mike Berman, Roni Einav, Michael Katina, Yadin Kaufmann and Gill Zaphrir.
About Halma
Halma plc is a global group of life-saving technology companies. Our innovative products and solutions address many of the key issues facing the world today. Together, we have a purpose that drives everything we do: Growing a safer, cleaner, healthier future for everyone, every day.
Our purpose defines the three broad market areas where we operate:
Safety: protecting life as populations grow and urbanise and protecting worker safety.
Environment: improving food and water quality, and monitoring air pollution.
Health: meeting rising healthcare demand as growing populations age and lifestyles change.
We employ over 7,000 people in more than+ 20 countries, with major operations in the UK, Europe, the USA and Asia Pacific. Halma is listed on the London Stock Exchange (LON: HLMA) and is a member of the FTSE 100 index.
About Owlytics
Owlytics Healthcare is a rapidly-growing company dedicated to improving the lives of seniors by combining continuous personal monitoring with the predictive power of data analytics. The company developed a continuous, AI-based monitoring solution that collects, analyses and reports personal health data in order to administer preventative solutions in real time.
Company’s core differentiators:
- Elevating personalized senior care with proven fall prevention and detection
- Infrastructure-free solution with immediate and reliable cellular coverage anywhere
- Medicare reimbursement available for our continuous health monitoring solution
The company was founded in 2016 by: Gill Zaphrir (CEO) Yaron Recher (VP R&D) Professor Varda Shalev (Medical Informatics adviser) Professor Yehonathan Sharabi (Medical Research adviser) and Professor Ronen Feldman (Machine Learning and NLP expert).
